Ovarian reserve and IVF outcomes after ethanol ovarian sclerotherapy in women with endometrioma: a systematic review and meta-analysis
meta-analysis
OA: closed
CC0
⤵ 5 in-corpus citations
AI-generated summary
This systematic review and meta-analysis examined the impact of ethanol ovarian sclerotherapy on ovarian reserve and IVF outcomes in women diagnosed with endometriomas.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Sclerotherapy has emerged as a promising treatment for endometrioma, a gynaecological condition characterized by high recurrence and significant impacts on fertility. Unlike traditional surgery, sclerotherapy offers the advantage of preserving ovarian reserve; however, limited data exist regarding its effects on women of reproductive age undergoing IVF. This study compared ovarian reserve and IVF outcomes between ethanol-only sclerotherapy and cystectomy for endometrioma. A systematic search PubMed, Embase, Scopus, Google Scholar, Medline, ClinicalTrials.gov and the Cochrane Central register of controlled trials was conducted using the keywords 'sclerotherapy and endometrioma', 'cystectomy and endometrioma' and 'sclerotherapy'. A total of 28 studies involving 1877 patients were included in the analysis, demonstrating that sclerotherapy significantly preserved ovarian reserve, as evidenced by a smaller change in anti-Müllerian hormone concentrations compared with cystectomy. Additionally, IVF outcomes favoured sclerotherapy, with higher clinical pregnancy rates and an increased number of total oocytes, metaphase II oocytes and embryos. However, the differences in fertilization rates and gonadotrophin dosage were not significant. Based on these findings, sclerotherapy should be considered as a viable treatment option for women with endometrioma, particularly for those with low ovarian reserve who are concerned about their future fertility. This treatment appears to offer the dual benefits of preserving ovarian function and enhancing fertility outcomes after treatment.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (50)
- Aspiration and ethanol sclerotherapy to treat recurrent ovarian endometriomas prior to in vitro fertilization – a pilot study via openalex
- Assessing the efficacy of aspiration and ethanol injection in recurrent endometrioma before IVF cycle: A randomized clinical trial. via openalex
- Assisted reproductive technique outcomes in patients with endometrioma undergoing sclerotherapy vs laparoscopic cystectomy: Prospective cross‐sectional study via openalex
- Catheter-directed Sclerotherapy for Ovarian Endometrioma: Short-term Outcomes via openalex
- Changes in anti-müllerian hormone after ultrasound guided aspiration and ethanol sclerotic therapy of ovarian cyst via openalex
- Comparison of the Effect on the Ovarian Reserve of Modern Methods of Treatment of Endometrioid Cysts via openalex
- Comparison of the therapeutic efficacy and ovarian reserve between catheter-directed sclerotherapy and surgical excision for ovarian endometrioma via openalex
- Correlation between ovarian chocolate cyst and serum carbohydrate antigen 125 level and the effect of ultrasound‐guided interventional sclerotherapy on serum carbohydrate antigen 125 level via openalex
- Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas via openalex
- Effect of catheter-directed ethanol sclerotherapy on ovarian reserve in patients with recurrent endometrioma: comparative analysis with primary endometriosis via openalex
- Efficacy of ablation and sclerotherapy for the management of ovarian endometrioma: A narrative review via openalex
- Efficacy of ethanol sclerotherapy for ovarian endometriomas via openalex
- Endometrioma and assisted reproductive technology: a review via openalex
- Endometrioma ethanol sclerotherapy could increase IVF live birth rate in women with moderate-severe endometriosis via openalex
- Ethanol sclerotherapy of endometriomas prior to IVF/ICSI improves progressive pregnancy and live birth rate via openalex
- Ethanol sclerotherapy of ovarian endometrioma: a safe and effective minimal invasive procedure. Preliminary results via openalex
- Ethanol Sclerotherapy versus Laparoscopic Surgery for Endometrioma Treatment: A Prospective, Multicenter, Cohort Pilot Study via openalex
- Impact of Endometriosis Surgery on In Vitro Fertilization/Intracytoplasmic Sperm Injection Outcomes: a Systematic Review and Meta-analysis via openalex
- Impact of Laparoscopic Sclerotherapy for Ovarian Endometriomas on Ovarian Reserve via openalex
- Is ovarian reserve reduction following endometriotic cystectomy predicted? The implication for fertility preservation counseling via openalex
- Laparoscopic Ethanol Sclerotherapy for Ovarian Endometriomas: Preliminary Results via openalex
- Management of transvaginal ultrasound-guided absolute ethanol sclerotherapy for ovarian endometriotic cysts via openalex
- Ovarian reserve after treatment of ovarian endometriomas by ethanolic sclerotherapy compared to surgical treatment via openalex
- Pretreatment for Ovarian Endometrial Cyst before in vitro Fertilization via openalex
- Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis via openalex
- Sclerotherapy with Ethanol: An Effective and Safe Alternative to Potentially Complex Surgical Treatment of Recurrent Ovarian Endometrioma via openalex
- Surgical Management of Ovarian Endometrioma: Impact on Ovarian Reserve Parameters and Reproductive Outcomes via openalex
- Surgical resection or aspiration with ethanol sclerotherapy of endometrioma before<i>in vitro</i>fertilization in infertilie women with endometrioma via openalex
- Therapeutic Efficacy of Catheter-directed Ethanol Sclerotherapy and Its Impact on Ovarian Reserve in Patients with Ovarian Endometrioma at Risk of Decreased Ovarian Reserve: A Preliminary Study via openalex
- Transvaginal ethanol sclerotherapy for an endometrioma in 10 steps via openalex
- [Ultrasonically guided puncture of endometrial cysts--aspiration of contents and infusion of ethanol]. via openalex
- Ultrasound-guided aspiration and ethanol sclerotherapy for treating endometrial cysts via openalex
- W6854339206 via openalex
- W2029834108 via openalex
- W2045264967 via openalex
- W2118598742 via openalex
- W2309188263 via openalex
- W2891240559 via openalex
- W2970684805 via openalex
- W3047889783 via openalex
- W4210320218 via openalex
- W4214754424 via openalex
- W4297143688 via openalex
- W4366084983 via openalex
- W4386627490 via openalex
- W4387501314 via openalex
- W6629636846 via openalex
- W6682708939 via openalex
- W6698325590 via openalex
- W6767567325 via openalex
Cited by (7)
- Minimally Invasive Innovation in Endometriosis and Adenomyosis: Toward Fertility Preservation and Symptom Relief 2026
- Identifying key determinants of cumulative live birth in women with ovarian endometrioma undergoing ethanol sclerotherapy followed by in vitro fertilization or intracytoplasmic sperm injection: an interpretable machine learning analysis 2026
- Beyond the Mass Effect: Decoupling Endometrioma Size and Bilaterality from Ovarian Reserve Depletion 2026
- Embryo Euploidy Rates and Reproductive Outcomes Following Ethanol Sclerotherapy, Laparoscopic Cystectomy, or No Intervention for Ovarian Endometriomas Prior to IVF with PGT-A: A Retrospective Cohort Study 2026
- Changing the paradigm of endometriosis - from diagnosis to integrated long-term management: a joint society opinion paper 2026
- Response to: Ethanol sclerotherapy for endometrioma management: what is the level of evidence? 2025
- Ethanol sclerotherapy for endometrioma management: what is the level of evidence? 2025
Source provenance
- europepmc
- last seen: 2026-08-13T06:15:24.848197+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-08-13T06:12:21.078239+00:00
License: CC0
· commercial use OK